Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$78.25 - $107.92 $2.95 Million - $4.07 Million
-37,682 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$97.82 - $116.09 $1.02 Million - $1.21 Million
-10,445 Reduced 21.7%
37,682 $3.7 Million
Q2 2018

Aug 14, 2018

BUY
$97.62 - $120.59 $2.24 Million - $2.77 Million
22,981 Added 91.39%
48,127 $5.57 Million
Q1 2018

May 15, 2018

BUY
$95.91 - $107.26 $2.41 Million - $2.7 Million
25,146 New
25,146 $2.48 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.